PEDLAR VENTURESContext
Covalon Technologies is an advanced medical products company in wound care and surgical biomaterials. The task: commercialize its technology, scale internationally, and mature the business into a disciplined public company on the TSX Venture Exchange.
From the operating seat
Brian took the CEO seat — the same "capital plus the operator" model Pedlar Ventures now offers — and led product development, international commercialization, and public-company finance and governance across a roughly thirteen-year tenure.
Results
- Revenue grew roughly 30× under his leadership.
- 10 FDA-cleared product families launched.
- Distribution built across more than 20 countries.
- A ~13-year CEO tenure (2010 – September 2023).
- Listed on the TSX Venture Exchange (TSXV: COV; OTCQX: CVALF).
What this proves: taking the operating seat alongside capital is how growth actually happens — the core Pedlar Ventures thesis.
Related services: Investment · Executive Services | About Brian Pedlar →